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Background: Schistosoma mansoni was moderately-highly endemic in the northeast of Sierra Leone. The national
neglected tropical disease control program started mass drug administration (MDA) with praziquantel (PZQ) in six
districts in 2009 targeting primary school children only. The effort was scaled-up to seven districts in 2010 targeting
school aged children (SAC) and at-risk adults. A cross-sectional sentinel site survey was conducted in 2012 after
three rounds of MDA to evaluate the impact of the national program.
Methods: Twenty-six (26) sentinel sites were randomly selected from the baseline mapping survey sites stratified
according to the baseline prevalence into high, moderate or low endemic category. Fifty (50) school children
(25 males and 25 females) were randomly selected per site. Fresh stool samples were examined in the field using
the Kato Katz technique. The results were compared with the baseline data.
Results: Program coverage of 94.8%, 77.1% and 81.7% was reported in 2009, 2010 and 2011 respectively.
Independent monitoring in 2011 showed program coverage of 83.9%, not significantly different from the reported
result in the same year. The overall prevalence of S. mansoni was 16.3% (95% CI: 14.4-18.4%) and mean intensity
was 18.98 epg (95% CI: 11.46-26.50 epg) in 2012, representing 67.2% and 85.9% reduction from the baseline
respectively. The proportion of moderately and heavily infected children was 3.3% and 1.2%, a significant reduction
from 18.2% and 8.8% at baseline respectively.
Conclusions: Sierra Leone has maintained effective MDA coverage with PZQ since 2009. Three rounds of MDA led
to a significant reduction of S. mansoni infection in the country. In line with the significant progress made in
controlling schistosomiasis, the national treatment strategy has been reviewed and MDA will be expanded to
include school age children in low endemicity districts with the new national objective for the elimination of
schistosomiasis. Sierra Leone is well on its way to eliminate schistosomiasis as a public health problem.
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Schistosomiasis inflicts great health and socioeconomic
burdens on the poorest populations in both rural and
non-rural settings of the tropics and subtropics, particu-
larly in sub-Saharan Africa [1,2]. It is estimated that over
200 million people are infected with schistosomes world-
wide, and schistosomiasis alone results in 200,000 deaths
per year in sub-Saharan Africa [1,3]. Infected children* Correspondence: mhodges@hki.org
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stated.that have marginal levels of adequate nutrition are at risk
of growth retardation, impaired cognition, and micronu-
trient deficiencies [4-7]. These factors combine to reduce
school attendance and to impair educational performance,
which, in turn, lead to a reduction in future productivity
and wage-earning capacity [8,9].
The global effort in the integrated control of the
neglected tropical diseases (NTDs) currently targets five
major ‘tool-ready’ diseases with preventive chemother-
apy (PC): lymphatic filariasis (LF), onchocerciasis, schis-
tosomiasis, soil-transmitted helminthiasis (STH) and
trachoma [10]. The World Health Organization (WHO)td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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communities (prevalence ≥50%), all school aged chil-
dren (SAC) and ‘at risk’ adults should be treated with
praziquantel (PZQ) annually. In moderately endemic
communities (prevalence ≥10% and <50%), all SAC and
‘at risk’ adults should be treated biennially. In low en-
demic communities (prevalence <10%), all SAC should
be treated twice during their primary school years [11].
‘At risk’ adults include all those who have contact with
contaminated fresh water sources: fishermen, farmers,
alluvial miners, and those households that wash/play in
schistosomiasis-contaminated water.
In Sierra Leone, the integrated national NTD control
program (NTDCP) started in 2008 with financial support
from the United States Agency for International Develop-
ment (USAID) and technical assistance from Helen Keller
International (HKI). One of the original goals of the na-
tional NTDCP was to reduce schistosomiasis prevalence
in all districts to <10% [12].
Both forms of intestinal and urogenital schistosomiasis
have been recognized as endemic in Sierra Leone [13,14].
National mapping in 2008 to 2009 confirmed that the distri-
bution of schistosomiasis was widespread, with moderate-
high prevalence in the north-eastern part of the country
[15-17]. Mass drug administration (MDA) with PZQ was
implemented in seven moderately-highly endemic districts:
Kailahun, Kono, Koinadugu, Kenema, Bo, and the north-
eastern chiefdoms of Tonkolili and Bombali. In 2009, MDA
was piloted in six districts, targeting only school-going
children. In 2010, MDA was scaled-up to target all SAC
and at risk adults (in this case, all rural adults are at risk) in
moderately-highly endemic chiefdoms for seven districts.
The treatment frequency within districts varies according
to the prevalence level in each chiefdom. Independent
monitoring was conducted after MDA to assess drug cover-
age in 2011. A sentinel site survey was also conducted in
2012 after three rounds of MDA to assess the progress of
the national NTDCP. The current paper presents the sur-
vey results and discusses the future treatment strategies, in
line with the new global objective for the elimination of
schistosomiasis.
Methods
MDA and data reporting
In Sierra Leone, PZQ was administered by the peripheral
health unit (PHU) staff. This decision was made by the
NTDCP at the beginning of the program due to the po-
tential side effects of the PZQ treatment in the popu-
lation that had never been treated. Each year, before
MDA, PHU staff receives training or refresher training
on PZQ distribution, including use of the dose poles, eli-
gibility of the target population, data recording and
reporting, and knowledge and management of potential
side effects. Following social mobilization, school-goingchildren received treatment at school-based distribution
points, and out-of-school children and ‘at risk’ adults
accessed treatment via community-based distribution.
PHU staff update the registers for each village in their
catchment areas before each MDA and estimate the
drug need. They used tally sheets to record the number
of PZQ administered during MDA. At the end of MDA,
the PHU staff reported the population and treatment
numbers to health districts that in turn, collated the data
in each district and reported to the NTDCP.Independent monitoring on MDA coverage
In July 2011, independent monitoring to assess program
coverage, as described previously [18], was conducted seven
days after the MDA. At least three villages were sampled
per district, with 1 village from a WHO list of consistently
low performing villages during immunization campaigns
(WHO Sierra Leone, unpublished observation). Independ-
ent monitors used simple tally sheets to interview 60 SAC
(30 males and 30 females), from classes 5–6 or 12–14 years
of age in selected schools, and 60 adults in communities on
whether they could recall taking PZQ. Independent mo-
nitoring was conducted in the seven endemic districts:
Kailahun, Kono, Koinadugu, Kenema, Bo, Tonkolili and
Bombali. In the community survey, independent moni-
tors conducted interviews in both public locations and
in randomly selected households. The results were com-
pared with the NTDP reported coverage.Sentinel site selection
This study was conducted in February 2012, seven months
after the last MDA in 26 sentinel sites in the seven
moderately-highly endemic districts. The sentinel sites
were randomly selected from the baseline mapping survey
sites, which were stratified according to the baseline
prevalence into high, moderate or low endemic category.
It was intended to select two sites from each endemic cat-
egory within each district. Details of the baseline surveys
have previously been described elsewhere [15,16]. Thus,
six sites were selected from Tonkolili district since it
had all three prevalence categories, five sites from Bombali,
four sites in both Kenema and Bo, three sites from
Kailahun and two sites in Kono and Koinadugu districts
respectively. In total, 12 sites had high baseline prevalence,
10 sites had moderate baseline prevalence and four sites
had low baseline prevalence. The locations and baseline
prevalence of each site is shown in Figure 1. In Bombali
district, one heavily endemic site received two rounds of
MDA (2010 and 2011) while the remaining four moder-
ately endemic sites had received only one round of MDA
in 2010. Yoni chiefdom in Tonkolili district had no MDA
because of its low prevalence at baseline.
Figure 1 Sentinel site locations and S. mansoni prevalence in Sierra Leone. Numbers in blue represent the prevalence value at the baseline
(the former) and after 3 rounds of MDA (the latter) for each sentinel site.
Sesay et al. Parasites & Vectors 2014, 7:14 Page 3 of 9
http://www.parasitesandvectors.com/content/7/1/14Sampling and data collection
A total of 50 SAC (25 males and 25 females) aged 10–
14 years who were in the upper classes (classes 5–6) were
randomly selected from each primary school in each site,
according to WHO recommendations [19]. Each child
was given a unique ID number, and their name, sex and
age were recorded. Once recorded, each child was given
one plastic container and asked to provide a fresh stool
sample. All stool samples were examined (1 slide per
sample) within five hours of collection by the Kato-Katz
method and using a 41.7 mg thick faecal smear template
[20,21]. All positive slides and 10% of all negative slides
were re-examined in the field by the more senior tech-
nicians for quality assurance. The number of S. mansoni
eggs per gram of faeces was calculated by using a multi-
plier factor of 24.
Data analysis
Overall, 1,286 children (642 males and 644 females)
were examined in the 26 sentinel sites during 2012. Theresults were compared to the data from the same sites sur-
veyed at baseline (770 children: 373 males and 396 fe-
males, with one missing data point for sex). Data were
analysed using SPSS statistical software (IBM, version 19).
The SPSS Complex Samples Crosstabs was used to calcu-
late the prevalence and the Complex Samples Descriptives
was used to calculate the intensity of infection with 95%
confidence intervals, taking into consideration the cluster
nature of school children using district as strata and
school as clusters. Samples were weighted according to
the population sizes in the surveyed districts when calcu-
lating the overall prevalence and intensity of infection.
The arithmetic mean intensity of infection from all the ex-
amined subjects (including both positive and negative)
was used in the analysis. The individual S.mansoni infec-
tion was categorized as heavy (≥400 epg), moderate (100–
399 epg), and light (1–99 epg) infections [22]. The Chi-
square test was used to compare the prevalence, and the
Kruskal Wallis test was used to compare the mean inten-
sity of infection between 2009 and 2012. GPS coordinates
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CA) was used to plot sentinel site locations and prevalence
level.
Ethical considerations
Ethical approval for the survey was obtained from the
Ministry of Health and Sanitation, Sierra Leone. Com-
munity informed consent was obtained following dis-
cussion with District Medical Officers, Chiefdom school
inspectors, head teachers and community-teachers as-
sociations. All communities included in the sentinel
sites were sensitised prior to sample collection. Verbal
individual consent was obtained from parents/carers as
literacy rates are low in these communities. Children
were also given information on the purpose of the activ-
ity prior to sample collection.
Results
MDA coverage
The reported annual treatment numbers and coverage
by district are shown in Table 1. In 2009, targeted indi-
viduals were only primary school children, and in 2010
and 2011, the treatment expanded to include SAC both
in and out of school and ‘at risk’ adults. Accordingly,
562,980 school children were treated in 2009 with pro-
gram coverage of 94.8%; 1,831,383 persons were treated
in 2010 with program coverage of 77.1%; and 1,781,037
persons were treated in 2011 with program coverage of
81.7%. Specifically for SAC in 2010 and 2011, 403,212
and 540,103 SAC were treated respectively for programTable 1 Sierra Leone schistosomiasis treatment numbers and
District
2009 reported 2010 reported
Targeted Treated % Targeted Treated %
Bo
- - - 278,547 223,096 8
(121,467) (110,300) (90.8) (75,679) (63,545) (84




- - - 417,899 336,014 8
(86,631) (84,118) (97.1) (97,556) (84,030) (86
Kenema
- - - 532,807 416,974 7
(156,496) (151,203) (96.6) (100,439) (84,868) (84
Koinadugu
- - - 387,289 261,416 6
(62,278) (55,725) (89.5) (59,121) (50,631) (85
Kono
- - - 422,204 326,535 7
(99,553) (97,279) (97.7) (84,468) (72,917) (86
Tonkolili
- - - 201,088 160,095 7
(67,276) (64,355) (95.7) (50,122) (43,282) (86
Overall
- - - 2,375,539 1,831,383 77
(593,701) (562,980) (94.8) (471,947) (403,212) (85
Note: Figures for SAC are shown in brackets.coverage of 85.4% and 86.0% in the SAC population
accordingly.
In the 2011 independent monitoring, a total of 8,505
persons were interviewed, 7,132 persons recalled taking
PZQ. This gave overall treatment coverage of 83.9% in
people interviewed, and 89% in SAC (Table 1). Compared
with the reported coverage in the same year, there was no
significant difference between the reported coverage and
the survey results (p > 0.05).
Prevalence of S. mansoni infection
The prevalence of S. mansoni infection from the sentinel
sites is shown in Table 2 and Figure 1. The adjusted overall
prevalence in all seven districts in 2012 was 16.3% (95%
CI: 14.4-18.4%). This prevalence represents a 67.2% reduc-
tion from the baseline of 49.7% (95% CI: 46.2-53.3%) in
2009 (p < 0.001). Across the seven districts, except in
Bombali where a 36% reduction was seen (p < 0.05), the
other six districts had a 56-98% reduction in prevalence
(p < 0.001). According to the baseline endemicity level,
there was no significant change in prevalence in sites
where the baseline endemicity level was low (p > 0.05),
while there were significant reductions (68-70%) in preva-
lence in sites where the baseline endemicity level was
moderate or high (p < 0.001). There was a similar reduc-
tion in prevalence in boys and girls.
Intensity of S. mansoni infection
Table 3 summarizes the intensity of infection in 2009
and 2012. The adjusted mean intensity of infection incoverage 2009-11
2011 reported 2011 IM results
Targeted Treated % Interviewed Recalled %
0.1 183,192 151,887 82.9 660 500 75.8
.0) (113,500) (98,196) (87.0) (360) (288) (80.0)
9.0 21,810 17,921 82.2 720 625 86.8
.3) (32,394) (29,756) (92.0) (360) (314) (87.2)
0.4 438,952 364,249 83.3 1,414 1,138 80.5
.1) (97,556) (84,444) (87.0) (707) (599) (84.7)
8.3 530,803 423,864 79.9 1,693 1,574 93.0
.5) (102,443) (89,764) (88.0) (754) (671) (89.0)
7.5 341,987 274,206 80.2 1,620 1,306 80.6
.6) (72,521) (50,631) (70.0) (720) (692) (96.1)
7.3 495,787 405,123 81.7 1,438 1,261 87.7
.3) (73,362) (68,369) (93.0) (720) (648) (90.0)
9.6 168,383 143,787 85.4 960 728 75.8
.4) (135,069) (118,943) (86.0) (480) (389) (81.0)
.1 2,180,914 1,781,037 81.7 8,505 7,132 83.9
.4) (626,845) (540,103) (86.0) (2,467) (2,195) (89.0)
Table 2 S. mansoni prevalence at sentinel sites in 2009 and 2012 in Sierra Leone
2009 2012 Change
(%)Number examined Prevalence (%) (95% CI) Number examined Prevalence (%) (95% CI)
Overall 770 49.7 (46.2 - 53.3) 1290 16.3 (14.4 - 18.4) −67.2
By district
Bo 119 25.2 (18.3 - 33.7) 198 0.5 (0.1 - 2.8) −98.0
Bombali 142 27.5 (20.8 - 35.3) 239 17.6 (13.3 - 22.9) −36.0
Kailahun 90 60.0 (49.7 - 69.5) 149 16.8 (11.6 - 23.6) −72.0
Kenema 119 60.5 (51.5 - 68.8) 199 17.1 (12.5 - 22.9) −71.7
Koinadugu 60 83.3 (72.0 - 90.7) 100 36.0 (27.3 -45.8) −56.8
Kono 60 65.0 (52.4 - 75.8) 101 20.8 (14.0 - 29.7) −68.0
Tonkolili 180 35.0 (28.4 - 42.2) 304 12.2 (9.0 - 16.3) −65.1
By baseline endemicity
Low 118 4.1 (1.3 - 10.7) 201 8.7 (4.7 - 14.3)* 112.2
Moderate 294 24.7 (19.8 - 30.0) 498 7.4 (5.3 - 10.1) −70.0
High 358 74.5 (70.1 - 78.4) 591 23.6 (20.6 - 26.9) −68.3
By sex
Boys 373 52.8 (47.7 - 57.8) 645 17.0 (14.2 - 20.0) −67.8
Girls 396 46.7 (41.7 - 51.5) 644 15.7 (13.1 - 18.7) −66.4
*Change in prevalence in this group is not statistically significant (p = 0.109).
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11.46-26.50 epg). Compared with the baseline 134.53
epg (95% CI: 93.51-175.55 epg), there was a significant
85.9% reduction (p < 0.001). Across the seven districts,
61-99% reduction from the baseline was observed (p <Table 3 S. mansoni intensity of infection at sentinel sites in 2
2009
Number examined Mean intensity of infection (epg)(95% CI)
Overall 770 134.53 (93.51 - 175.55)
By district
Bo 119 35.09 (17.59 - 52.59)
Bombali 142 48.85 (27.67 - 70.02)
Kailahun 90 194.93 (116.14 - 273.73)
Kenema 119 191.60 (132.61 - 250.58)
Koinadugu 60 250.80 (180.44 - 321.16)
Kono 60 159.60 (87.16 - 232.04)
Tonkolili 180 91.33 (57.43 - 125.24)
By baseline endemicity
Low 118 9.25 (0–18.56)
Moderate 294 29.81 (19.14 - 40.48)
High 358 226.01 (153.79 - 298.23)
By sex
Boys 373 133.96 (80.79 - 187.13)
Girls 396 135.00 (72.98 - 197.02)
*Change in intensity of infection in this group is not statistically significant (p = 0.260.01). As for prevalence, there was no significant change
in mean intensity of infection in sites where the baseline
endemicity level was low (p > 0.05), while significant re-
duction by 70-88% was shown in sites where the base-
line endemicity level was moderate or high (p < 0.001). A009 and 2012 in Sierra Leone
2012
Change
(%)Number examined Mean intensity of infection (epg)(95% CI)
1290 18.98 (11.46 - 26.50) −85.9
198 0.12 (0–0.36) −99.7
239 18.68 (5.95 - 31.41) −61.8
149 19.33 (8.62 - 30.03) −90.1
199 25.69 (11.99 - 39.39) −86.6
100 42.72 (24.86 - 60.58) −83.0
101 10.22 (5.66 - 14.78) −93.6
304 24.87 (14.94 - 34.80) −72.8
201 15.50 (0–34.84)* 67.6
498 8.78 (2.79 - 14.76) −70.5
591 26.41 (13.18 - 39.64) −88.3
645 19.30 (9.30 - 29.30) −85.6
644 18.69 (7.45 - 29.94) −86.2
).
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was seen (both p < 0.001).
At baseline in 2009, 27% school age children were
moderately or heavily infected with S.mansoni: 8.8%
heavily and 18.2% moderately. After three years of im-
plementation of MDA, the overall proportion of children
moderately or heavily infected with S.mansoni was sig-
nificantly reduced to 4.5%: 1.2% heavily and 3.3% moder-
ately in 2012 (Figure 2).
Discussion
Praziquantel MDA for schistosomiasis in Sierra Leone
is part of the integrated national NTD control program.
According to the national baseline mapping [15-17],
seven districts (Kailahun, Kono, Koinadugu, Kenema,
Bo, Tonkolili and Bombali) had moderate or high levels
of endemicity (prevalence ≥10% and <50%); five districts
(Moyamba, Port Loko, Kambia, Pujehun and Rural
Western Area) had low levels of endemicity (prevelance
>0% and <10%); and two districts (Bonthe and Urban
Western Area) were non-endemic. As the first phase of
the control program, the PZQ distribution targets both
school age children and at-risk adults for morbidity
control in the seven moderately or highly endemic dis-
tricts. Over the last three years, 77-95% program coverage
has been achieved, which was validated by the independ-
ent monitoring survey. The high treatment coverage is
important in NTD control programs using preventive che-
motherapy strategy. The annual coverage achieved for
schistosomiasis in Sierra Leone has surpassed the 75%
coverage recommended by WHO [22]. The successful im-
plementation of MDA in Sierra Leone was largely due to
effective advocacy, social mobilization and program coord-
ination at all levels and assisted by the introduction ofFigure 2 Proportion (%) of different degrees of intensity of S. manson
Leone. Error bars represent the 95% confidence intervals.independent monitoring during and after MDA. Trained
independent monitors perform the ‘in process’ monitoring
during the MDA to help identify MDA weaknesses, such
as drug shortages, under-performing health workers, or
high refusal rates within particular communities or sub-
sections of communities, so that they could be reported to
the NTDCP, and swift remedial action could be taken.
They also perform the ‘end process’ monitoring after
the MDA to collect coverage data independently and to
validate the reported treatment coverage. Independent
monitors also collect qualitative information, such as the
misappropriation of MDA drugs, inappropriate dosage,
lack of training or lack of dose poles or tally sheets.
WHO recommends conducting sentinel site surveys
every 2–3 years after the start of the program implementa-
tion to assess the impact of the program [19]. As the first
MDA targeted only school going children, the sentinel site
survey was conducted after three years of MDA imple-
mentation when the communities and all school age chil-
dren had received at least two rounds of MDA. The total
cost for the survey was 13,260 US dollars, around 500 US
dollars per sentinel site. The results showed that the over-
all prevalence of S.mansoni infection was significantly re-
duced by 67%, ranging from 36% to 98% in individual
districts, and the intensity of infection was reduced by
85.9% with reductions ranging from 61% to 99% in various
districts. Among the 26 sentinel sites, those with moderate
or high endemicity levels at baseline showed significant re-
duction in both overall prevalence and mean intensity of
infection. 12 sites had high prevalence (>50%) in 2009,
and only two, which had 90% prevalence at baseline, still
showed over 50% prevalence in 2012. It is not surprising
that those sites with low endemicity level at baseline did
not show significant change, in either overall prevalencei infection in school age children in 2009 and in 2012 in Sierra
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priority areas. However, it was noted that one of these low
endemicity sites at baseline showed a significant increase
in infection level over the three years (data not shown),
suggesting that the national treatment strategy in low
endemicity areas needs to be reviewed. As described in
the previous publications, separate mapping surveys were
conducted for S. mansoni and S. haematobium [15,17].
Sentinel sites were selected based on the S. mansoni sur-
vey and most of the sites did not have S. haematobium
baseline data for comparison. Therefore, S. haematobium
data were not presented in this paper. It is also noted that
the current survey was conducted a few weeks after lym-
phatic filariasis MDA with albendazole and ivermectin,
STH data collected during the sentinel site survey were
not included as it would significantly overestimate the im-
pact of the program.
After two to three years of effective MDA, the WHO
estimates that <1.0% of SAC should be heavily infected
(>400epg) [19]. In our results, the proportion of heavy
infection was reduced from 8.8% to 1.2% after three
years of implementation. The severity of morbidity due
to schistosomiasis is associated with the intensity of in-
fection, especially in early childhood [23]. It is believed
that serious morbidity may have been avoided or re-
versed as a result of effective MDA. Similar gains have
been reported by other NTDCPs in both East and West
Africa in their progress towards S. mansoni control and
elimination [24-29]. Despite the success in reducing the
proportion of children heavily or moderately infected
to 1.2% and 3.3% respectively, continued MDA is still
needed to further bring down the prevalence and inten-
sity of infection in school age children. It should be
noted that there were 10.7% of children surveyed living
with low intensity of infection in the seven districts. The
consequences of morbidity due to light infections are
sometimes underestimated and hence, overlooked in
many control programmes. Recent studies have revealed
that considerable morbidity due to diarrhea, chronic
pain, under-nutrition, exercise intolerance and anaemia
can result from even light infections [23,27].
WHO recommends comprehensive control measures
to achieve the elimination of schistosomiasis [30-32]. In
Sierra Leone, like many other countries currently imple-
menting NTD control programs, the funding is limited to
MDA, which leaves the other components of NTD control
unfunded, such as water, sanitation and hygiene, and snail
control. There will be a risk of recrudescence when MDA
is stopped. In order to achieve the WHO target, there is a
need for a full control approach which includes provision
of safe water, improved personal hygiene and community
sanitation and, intensified case management, veterinary
public health at the human-animal interface, and vector
and intermediate host control [32,33].Sanitation is a major problem in Sierra Leone. Accord-
ing to the Demographic and Health Survey, conducted in
2008, 87% of the population does not have access to im-
proved toilet facilities [34]. The provision of proper sanita-
tion facilities: proper toilet, laundry, hand washing and
shower facilities and ensuring proper personal hygiene can
help to reduce the disease burden. The provision of proper
toilet facilities and ensuring that these toilets are used
would help to sustain the current achievement. According
to the same survey, 49.2% of the population does not have
access to a clean water source [34]. The absence of clean
drinking water can greatly increase the spread of water
borne diseases, and the provision of piped water has been
shown to reduce the prevalence of schistosomiasis in
SAC. In south-east Brazil, for example, research showed
that SAC were 2.3 times more likely to be infected if they
had no piped water in their homes, and in Zimbabwe, the
prevalence of S. mansoni among SAC who lived on com-
munal lands that lacked piped-water supply was 4.8%
compared to 0.8% of those that had piped water on the
same land [35,36].
Long-term schistosomiasis control and elimination will
require health education, safe water sources for washing,
and latrines in both schools and communities. In addition,
behaviour change communication is needed to ensure the
appropriate use of these facilities, to improve personal and
environmental hygiene, and to reduce risk of re-infection.
To this end, a closer collaboration among partners in rele-
vant sectors, particularly education and water, sanitation
and hygiene, is needed [37]. With the progress of the na-
tional program, the Ministry of Health and Sanitation will
need to work with partners to mobilize resources to sup-
port such activities.
The World Health Assembly (WHA) resolution 65.21
calls on Member States to intensify schistosomiasis control
efforts in most disease-endemic countries and to initiate
interventions towards the elimination of schistosomiasis in
low-transmission countries [31]. The WHO NTD control
roadmap and the schistosomiasis strategic plan (2012–
2020) have set the stage for the national control programs
to achieve the elimination of schistosomiasis [30,32]. The
results from the current survey show that Sierra Leone has
made significant progress in reducing morbidity due to
schistosomiasis in seven moderately or highly endemic
districts, as exemplified by the significant reduction in
S. mansoni infection and particularly, by the reduction in
the intensity of infection. In line with the new elimination
objectives set by WHO, the national NTDCP has reviewed
the national treatment strategy and decided to target
school age children for the next MDA in five coastal dis-
tricts (Moyamba, Port Loko, Kambia, Pujehun and Rural
Western area) where low prevalence (>0% and <10%) was
found during the national baseline mapping. It is expected
that a national re-assessment of the endemic situation of
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MDA according to the WHO recommendations [19], and
the treatment strategy will be re-aligned. It is hoped that
by adjusting the treatment strategy and expanding national
coverage, Sierra Leone will be on course to be one of the
first sub-Saharan African countries to achieve elimination
of schistosomiasis as a public health problem.Conclusions
The national NTD control program in Sierra Leone has
implemented PZQ MDA in seven moderately or highly en-
demic districts, targeting school age children and at-risk
adults for three years. Significant progress has been made
in reducing the prevalence and intensity of S. mansoni in-
fection, as shown by the sentinel site survey conducted in
2012. The national program has reviewed the current treat-
ment strategy and is expected to expand the treatment
coverage to include school age children in low endemicity
districts in alignment with the new national objective for
the elimination of schistosomiasis. Sierra Leone is well on
its way to eliminate schistosomiasis as a public health
problem.
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